MedPath

Spectramast

SPECTRAMAST LC

Approved
Approval ID

35017960-b3c3-4e05-803c-e4a8b7009d83

Product Type

PRESCRIPTION ANIMAL DRUG LABEL

Effective Date

Mar 26, 2025

Manufacturers
FDA

Zoetis Inc.

DUNS: 828851555

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ceftiofur hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54771-5279
Application NumberNADA141238
Product Classification
M
Marketing Category
C73593
G
Generic Name
ceftiofur hydrochloride
Product Specifications
Route of AdministrationINTRAMAMMARY
Effective DateMarch 26, 2025
FDA Product Classification

INGREDIENTS (3)

APRICOT KERNEL OIL PEG-6 ESTERSInactive
Code: DRG3KJZ1TJ
Classification: IACT
MICROCRYSTALLINE WAXInactive
Quantity: 700 mg in 10 mL
Code: XOF597Q3KY
Classification: IACT
CEFTIOFUR HYDROCHLORIDEActive
Quantity: 125 mg in 10 mL
Code: 6822A07436
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Spectramast - FDA Drug Approval Details